ARandomized Controlled Trial to Evaluate Magnesium Sulphate as an Adjuvant to 0.25 Percent Levobupivacaine in Ultrasound Guided Transversus Abdominis Plane Block for Postoperative Analgesia in Patients Undergoing Unilateral Inguinal Herniorraphy
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
- 试验地点
- 1
研究概览
简要总结
This randomized controlled trial aims to compare the efficacy of 0.25% levobupivacaine alone versus 0.25% levobupivacaine combined with 10% Magnesium Sulphate in ultrasound-guided Transversus Abdominis Plane (TAP) block for postoperative analgesia in patients undergoing unilateral inguinal herniorrhaphy. Patients will be randomly allocated into two groups to receive TAP block with either levobupivacaine alone or levobupivacaine with magnesium sulphate. Post-operative pain scores will be assessed using the Numerical Pain Rating Scale (NRS). The duration of analgesia, time to first rescue analgesic, and total analgesic consumption within the first 24 hours after surgery will be recorded and compared between the groups to evaluate whether the addition of magnesium sulphate improves the quality and duration of postoperative analgesia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant and Outcome Assessor Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients aged between 18-60 years Patients belonging to American Society Of Anesthesiologist (ASA) physical status grade I – II Patients undergoing elective unilateral inguinal hernia surgeries under subarachnoid block.
排除标准
- •Patients suffering from defect of spinal cord or any anatomical deformity of spine.
- •Patients having infections at the site of injection.
- •Patients with coagulopathy.
- •Patients with prior back surgery.
- •Patients with raised intracranial pressure.
- ••Patients with history of cardiac, respiratory,renal or hepatic diseases.
- ••Allergy to study medication or local Anaesthetic s.
研究者
Dr Jayanti Gupta
Swami Dayanand Hospital